Alps Advisors Inc Biocryst Pharmaceuticals Inc Transaction History

Alps Advisors Inc

$15.7 Billion
Q4 2024

A detailed history of Alps Advisors Inc transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Alps Advisors Inc holds 167,492 shares of BCRX stock, worth $1.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

167,492

Previous 158,110 5.93%

Holding current value

$1.52 Million

Previous $1.2 Million 4.83%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$7.03 - $8.43 $65,955 - $79,090	9,382 Added 5.93%	167,492 $1.26 Million
Q3 2024 Nov 12, 2024	SELL	$6.41 - $8.69 $18,544 - $25,140	-2,893 Reduced 1.8%	158,110 $1.2 Million
Q2 2024 Aug 13, 2024	BUY	$4.13 - $6.79 $64,415 - $105,903	15,597 Added 10.73%	161,003 $994,000
Q1 2024 May 14, 2024	BUY	$4.89 - $7.65 $35,721 - $55,883	7,305 Added 5.29%	145,406 $738,000
Q4 2023 Feb 14, 2024	SELL	$4.98 - $6.77 $8,710 - $11,840	-1,749 Reduced 1.25%	138,101 $827,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $6,522 - $7,698	972 Added 0.7%	139,850 $990,000
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $111,777 - $141,488	16,060 Added 13.08%	138,878 $977,000
Q1 2023 May 10, 2023	SELL	$7.94 - $11.84 $28,226 - $42,091	-3,555 Reduced 2.81%	122,818 $1.02 Million
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $260,757 - $352,642	24,834 Added 24.46%	126,373 $1.45 Million
Q3 2022 Nov 14, 2022	SELL	$10.79 - $14.81 $92,535 - $127,010	-8,576 Reduced 7.79%	101,539 $1.28 Million
Q2 2022 Aug 11, 2022	BUY	$7.89 - $17.88 $8,450 - $19,149	1,071 Added 0.98%	110,115 $1.17 Million
Q2 2018 Jul 25, 2018	SELL	$4.6 - $6.52 $105,694 - $149,810	-22,977 Reduced 17.4%	109,044 $535,000
Q1 2018 May 01, 2018	BUY	$4.35 - $5.82 $99,949 - $133,726	22,977 Added 21.07%	132,021 $630,000
Q4 2017 Feb 05, 2018	BUY	$4.16 - $5.33 $124,138 - $159,052	29,841 Added 37.68%	109,044 $535,000
Q3 2017 Nov 03, 2017	BUY	$4.1 - $5.97 $324,732 - $472,841	79,203	79,203 $415,000

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

169M

Call Options Held

930K

Put Options Held

1.03M

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.68B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Biocryst Pharmaceuticals Inc Transaction History